<p>Western blot analysis was performed to detect PTTG1 and actin proteins in human leukemia cell lines HL-60, K-562, HEL92.1.7, U937, THP1, PBMC (peripheral blood mononuclear cells) and mouse macrophage RAW264.7 and J774A.1 cells. Mouse J774A.1 cells were more differentiated, compared with the five less differentiated human leukemia cells. PBMC was used as a normal cell control.</p
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood cancer that comprises 10−15...
Chronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein tyrosine p...
<p>(<b>a</b>) Endogenous levels of <i>PTEN</i> mRNA in CML patients and normal donors were examined ...
Background. Chronic Myelogenous Leukemia (CML) is the most common myeloproliferative disease while ...
<div><p>The aberrant expression of proto-oncogenes is involved in processes that are responsible for...
<p>(<b>a</b>) BCR-ABL transcript expression was upregulated in all drug-resistant cells, whereas hig...
<p>The expression of SRPK1 and SRPK2 were analyzed by (A) Western blotting and (B) RT-qPCR assays in...
<p>In THP1 and HL-60 cells, the activation of PKC/ERK/KLF6 signaling axes contributes to PTTG1 suppr...
The aberrant expression of proto-oncogenes is involved in processes that are responsible for cellula...
<p>Cells (100.000/ mL) were plated and lysed after 24 h. (<b>A</b>) The expression of P-gp and LMW-P...
<p>THP1 cells were pretreated with vehicle (veh, 0.1% DMSO), bisindolylmaleimide I (BIM, 5 µM) or U0...
The tumor suppressor gene PTEN is inactivated in many human cancers. However, it is unknown whether ...
Chronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein tyrosine p...
A small population of cancer stem cells named the ‘‘side population’ ’ (SP) has been demonstrated to...
In an effort to identify novel drugs targeting fusion-oncogene induced acute myeloid leukemia (AML),...
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood cancer that comprises 10−15...
Chronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein tyrosine p...
<p>(<b>a</b>) Endogenous levels of <i>PTEN</i> mRNA in CML patients and normal donors were examined ...
Background. Chronic Myelogenous Leukemia (CML) is the most common myeloproliferative disease while ...
<div><p>The aberrant expression of proto-oncogenes is involved in processes that are responsible for...
<p>(<b>a</b>) BCR-ABL transcript expression was upregulated in all drug-resistant cells, whereas hig...
<p>The expression of SRPK1 and SRPK2 were analyzed by (A) Western blotting and (B) RT-qPCR assays in...
<p>In THP1 and HL-60 cells, the activation of PKC/ERK/KLF6 signaling axes contributes to PTTG1 suppr...
The aberrant expression of proto-oncogenes is involved in processes that are responsible for cellula...
<p>Cells (100.000/ mL) were plated and lysed after 24 h. (<b>A</b>) The expression of P-gp and LMW-P...
<p>THP1 cells were pretreated with vehicle (veh, 0.1% DMSO), bisindolylmaleimide I (BIM, 5 µM) or U0...
The tumor suppressor gene PTEN is inactivated in many human cancers. However, it is unknown whether ...
Chronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein tyrosine p...
A small population of cancer stem cells named the ‘‘side population’ ’ (SP) has been demonstrated to...
In an effort to identify novel drugs targeting fusion-oncogene induced acute myeloid leukemia (AML),...
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood cancer that comprises 10−15...
Chronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein tyrosine p...
<p>(<b>a</b>) Endogenous levels of <i>PTEN</i> mRNA in CML patients and normal donors were examined ...